��������

John Kurek is a seasoned investment director with extensive experience in the biotechnology sector and venture capital. Since March 2007, John has been with Uniseed, Australia's longest-running venture fund, serving as Investment Director and Manager. In addition, John holds several non-executive director positions at various clinical-stage biotechnology companies including Certa Therapeutics, Kinoxis Therapeutics, Exonate, OccuRx, Q-Sera Pty Ltd, Currus Biologics, Ena Respiratory, and Axelia Oncology. John’s educational background includes a PhD in Neuroscience from the University of Melbourne, along with degrees in Biochemistry and Drug Evaluation & Pharmaceutical Science.